{"id":"elonva","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":["corifollitropin alfa"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Follicle-stimulating hormone receptor"},"_scrapedAt":"2026-03-27T23:29:07.662Z","_scrapedBy":"cloudflare-swarm","_wikipedia":{"url":"https://en.wikipedia.org/wiki/Gonadotropin_preparations","title":"Gonadotropin preparations","extract":"Gonadotropin preparations are drugs that mimic the physiological effects of gonadotropins, used therapeutically mainly as fertility medication for ovarian hyperstimulation and ovulation induction. For example, the so-called menotropins consist of LH and FSH extracted from human urine from menopausal women. There are also recombinant variants."},"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Adolescent males with hypogonadotropic hypogonadism","diseaseId":"adolescent-males-with-hypogonadotropic-hypogonadism","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Ovulation induction","diseaseId":"ovulation-induction","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06134479","phase":"PHASE3","title":"Comparison of Sequential CFA vs CFA +rFSH for Elective Fertility Preservation.","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-12-12","conditions":"Fertility","enrollment":194},{"nctId":"NCT06175832","phase":"PHASE4","title":"PPOS (Progestin Primed Ovarian Stimulation) and Corifollitropin Alfa (CFA) Cross-over Study","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2025-01-27","conditions":"Ovarian Stimulation, Quality of Life, Preimplantation Genetic Testing","enrollment":60},{"nctId":"NCT06877429","phase":"","title":"Is the Diurnal Variation in Circulating Levels of Cortisol Reflected in Follicular Fluid of Preovulatory Follicles Close to Ovulation?","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Healthy","enrollment":20},{"nctId":"NCT06879002","phase":"","title":"Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Stimulation in the Ovary, IVF Outcome","enrollment":252},{"nctId":"NCT06193135","phase":"NA","title":"Usefulness of Corifollitropin α as Alternative to Conventional Daily rFSH Protocols in Oocyte Donors Undergoing Pituitary Suppression With Medroxiprogesterona Acetate (MPA)","status":"RECRUITING","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2025-07-08","conditions":"Infertility, Female, Reproductive Sterility","enrollment":318},{"nctId":"NCT03019575","phase":"PHASE3","title":"Efficacy and Safety of Corifollitropin Alfa (MK-8962) in Combination With Human Chorionic Gonadotropin (hCG) in Adolescent Males With Hypogonadotropic Hypogonadism (HH) (MK-8962-043)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2017-02-02","conditions":"Hypogonadotropic Hypogonadism","enrollment":17},{"nctId":"NCT04446845","phase":"PHASE4","title":"Double Stimulation Followed by a Fresh Embryo Transfer","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2020-10-30","conditions":"Infertility","enrollment":120},{"nctId":"NCT03197077","phase":"PHASE3","title":"Optimisation of Follicular Recruitment in IVM Cycles","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2017-11-01","conditions":"Infertility, Female, Polycystic Ovary Syndrome","enrollment":145},{"nctId":"NCT02402192","phase":"PHASE4","title":"Type of Gonadotropin and Embryo Kinetics of Development","status":"TERMINATED","sponsor":"IVI Madrid","startDate":"2015-04","conditions":"Infertility","enrollment":201},{"nctId":"NCT01408615","phase":"","title":"A Post Marketing Observational Study of the Safety and Efficacy of Elonva (Corifollitropin Alfa) in General Practice (P08165)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2011-09-20","conditions":"Infertility, Female","enrollment":472},{"nctId":"NCT03208972","phase":"PHASE4","title":"Elonva in Combination With Hp-FSH Versus Elonva With Low Dose hCG","status":"COMPLETED","sponsor":"AZ Jan Palfijn Gent","startDate":"2014-10","conditions":"Infertility","enrollment":107},{"nctId":"NCT03877185","phase":"","title":"A New Revolutionary 3-Injection- Protocol in Infertile Women","status":"UNKNOWN","sponsor":"Assisting Nature","startDate":"2018-07-01","conditions":"Infertility, Female","enrollment":100},{"nctId":"NCT04416607","phase":"NA","title":"Corifollitropin Alpha and Ovarian Response","status":"COMPLETED","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2018-06-15","conditions":"Infertility, Female","enrollment":300},{"nctId":"NCT04142190","phase":"","title":"Corifollitropin Alfa and Embryo Morphokinetics","status":"COMPLETED","sponsor":"Kinderwunsch Institut GmbH","startDate":"2013-01","conditions":"Infertility","enrollment":1351},{"nctId":"NCT03177538","phase":"PHASE4","title":"Corifollitropin Alfa Combined With Menotropin Versus Follitropin and Lutropin Alfa in Expected Suboptimal Responders","status":"COMPLETED","sponsor":"D.O. Ott Research Institute of Obstetrics, Gynecology, and Reproductology","startDate":"2017-09-04","conditions":"Infertility, Female","enrollment":32},{"nctId":"NCT03686852","phase":"NA","title":"Effect of Recombinant Follicular Stimulating Hormone (FSH) Dosing Following Cori-follitropin Alfa","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2019-05-01","conditions":"Infertility","enrollment":261},{"nctId":"NCT02606500","phase":"PHASE4","title":"Efficacy of Corifollitropin Alfa in Obese Women in Terms of Clinical and Molecular Parameters of IVF Success","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2016-03","conditions":"Obesity","enrollment":70},{"nctId":"NCT02466204","phase":"PHASE4","title":"Efficacy of Corifollitropin Alfa Versus Follitropin Beta in Aged IVF (In-vitro Fertilization) Patients","status":"COMPLETED","sponsor":"Vietnam National University","startDate":"2015-06-01","conditions":"Infertility","enrollment":400},{"nctId":"NCT02414737","phase":"PHASE3","title":"Ovarian Stimulation Single Injection Elonva","status":"COMPLETED","sponsor":"Flinders Fertility","startDate":"2016-02","conditions":"Infertility","enrollment":20},{"nctId":"NCT02254928","phase":"PHASE4","title":"Corifollitropin Alfa Versus Daily rFSH in the Controlled Ovarian Stimulation of Poor Responders","status":"TERMINATED","sponsor":"Vida Recoletas Sevilla","startDate":"2014-09","conditions":"Infertility","enrollment":26},{"nctId":"NCT01206803","phase":"","title":"Ovarian Response Prediction in In Vitro Fertilization (IVF) Patients","status":"COMPLETED","sponsor":"University Hospital Schleswig-Holstein","startDate":"2010-09","conditions":"Infertility, Subfertility","enrollment":294},{"nctId":"NCT02213627","phase":"PHASE4","title":"Use of Corifolitropin Alfa in Oocyte Donors","status":"UNKNOWN","sponsor":"IVI Madrid","startDate":"2014-10","conditions":"Female Reproductive Problem, Infertility","enrollment":300},{"nctId":"NCT02471677","phase":"PHASE4","title":"Corifollitropin Alfa Versus Follitropin Beta in High Responders","status":"UNKNOWN","sponsor":"Eugonia","startDate":"2015-09","conditions":"Infertility","enrollment":62},{"nctId":"NCT01633580","phase":"PHASE4","title":"D2 Versus D4 Corifollitropin Alfa in GnRH Antagonists","status":"COMPLETED","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2011-12","conditions":"Infertility","enrollment":67},{"nctId":"NCT02215135","phase":"PHASE4","title":"Corifollitropin Alfa Application in PCOS Patients","status":"UNKNOWN","sponsor":"Shin Kong Wu Ho-Su Memorial Hospital","startDate":"2014-01","conditions":"In Vitro Fertilization","enrollment":30},{"nctId":"NCT02046655","phase":"PHASE4","title":"Corifollitropin Alfa Compared to Daily rFSH in Poor Responders Undergoing ICSI","status":"COMPLETED","sponsor":"Aristotle University Of Thessaloniki","startDate":"2011-01","conditions":"Subfertility","enrollment":80}],"_emaApprovals":[],"_faersSignals":[{"count":10,"reaction":"OVARIAN HYPERSTIMULATION SYNDROME"},{"count":6,"reaction":"ASCITES"},{"count":3,"reaction":"DIZZINESS"},{"count":3,"reaction":"DYSPNOEA"},{"count":3,"reaction":"PAIN"},{"count":2,"reaction":"ANGIOEDEMA"},{"count":2,"reaction":"EFFUSION"},{"count":2,"reaction":"INSOMNIA"},{"count":2,"reaction":"INTRA-ABDOMINAL FLUID COLLECTION"},{"count":2,"reaction":"ORAL HERPES"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":16,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Elonva","genericName":"Elonva","companyName":"University Medical Centre Ljubljana","companyId":"university-medical-centre-ljubljana","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}